July 14, 2008
Welichem Successfully Completes Phase I Clinical Trial (T-Net British Columbia)
Vancouver, BC, July 14, 2008–(T-Net)–Welichem Biotech (TSX-V: WBI) announced the successful completion of and the results from a randomized, double-blinded Phase I clinical trial done in Montreal, Canada, which evaluated topically applied WBI-1001 in 36 psoriasis patients.
Original post by Epinions Recent Content for Golf
Leave a comment
You must be logged in to post a comment.